If you’ve ever wondered about skin aging, you probably know a little something about collagen. Collagen is a protein that is responsible for the structure that supports the skin. With lots of collagen, the skin is firm, taut, and has few wrinkles.
The problem is after the age of 20, humans lose one additional percent of collagen production every year. When you reach 50, your collagen production is now down 30%! Welcome, loose skin and wrinkles!
Sculptra, a dermal filler, aims to replace some of that missing collagen. Dr. Lavey uses Sculptra to correct shallow to deep facial wrinkles and folds.
What is Sculptra?
With most fillers, their results are instant. They are injected and they “fill” the wrinkle from beneath, pushing the skin back up.
Sculptra is different; its results are not immediate. This filler is made from poly-L-lactic acid (PLLA), which works within the skin to replace lost collagen. Sculptra is the first facial injectable that gives you subtle results over time as collagen is replaced. This makes for a natural-looking appearance that improves over time, not an instant change as with other fillers. Dr. Lavey usually recommends two to four injection sessions over a few months for the best results. These results can then last for over two years!
How does Sculptra work?
Sculptra is injected into the deep dermal layer of the skin. Microparticles of PLLA work within the deep dermis to rebuild lost collagen and provide structural skin support. As the PLLA is absorbed a collagen framework is created. This reinforced collagen structure provides a foundation that gradually restores the look of fullness to shallow to deep wrinkles and folds.
Where is Sculptra effective?
Sculptra is effective for:
- The lines framing your mouth (marionette lines)
- Deep folds between the nose and mouth (nasolabial folds), also called smile lines
- Chin wrinkles
If you’re interested in Sculptra, check our summer special flyer in the “specials” section of this site. Otherwise, call Dr. Lavey for an appointment at 925-820-3633.
No comments yet.